Tech

Android VP Dave Burke Steps Down to Explore AI/bio Roles

After 14 years, Android Engineering VP Dave Burke steps down to pursue AI/bio projects within Alphabet, marking a new chapter in his career

Burke was involved in several significant initiatives, including the development of Chrome for mobile phones, the launch of Android TV, the construction of Nexus and Pixel phones, and the leadership of efforts to construct and distribute developer tools.

This occurred during a period in which Google had been restructuring its executive team amid redundancies this year.

The corporation terminated over one thousand employees in January, including most of its augmented reality hardware team. James Park and Eric Friedman, co-founders of Fitbit, resigned from their positions at the company.

In April, Google consolidated its hardware and Android teams to incorporate artificial intelligence into its products.

Hiroshi Lockheimer, previously responsible for Android, Chrome, and ChromeOS, began seeking alternative roles within the organization due to the company’s decision.

Google’s Hiroshi Lockheimer on the future of Android | The Telegraph

Directorship of the new division was assigned to Rick Osterloh, Senior Vice President of Devices and Services.

Rick Osterloh, Senior Vice President of Devices and Services | DerStandard

Sameer Samat, previously employed by Lockheimer, advanced to the position of president of Android Ecosystem.

Sameer Samat, Google takes aim at cheap phones, again, with Android Go – CNET

Burke announced in a post on X that he would continue to act as an advisor while he searches for a new endeavor.

“After fourteen years of overseeing Android engineering, I have realized it is time for a change.”

It is a remarkable voyage that contributes to the development of the world’s most extensive operating system and a significant number of Nexus and Pixel devices. The opportunity is one for which I will be eternally grateful.

He declared that he would persist in his role as an advisor while assessing the subsequent course of action in biology and artificial intelligence.

Dave Burke | X

Burke also sent a letter to his colleagues, subsequently published on LinkedIn.

In the letter, he expressed his intention to explore the potential of artificial intelligence in improving drug discovery.

“AI has the potential to play a pivotal role in accelerating drug discovery, with wide applicability, including in hard-to-treat pediatric cancers, a topic close to my heart. I’m working with Sundar to explore relevant roles at Alphabet,” he said.

Hillary Ondulohi

Hillary is a media creator with a background in mechanical engineering. He leverages his technical expertise to craft informative pieces on protechbro.com, making complex concepts accessible to a wider audience.

Share
Published by
Hillary Ondulohi

Recent Posts

Bitcoin Hashrate Hits 2022 Lows

The Bitcoin hashrate drawdown metric can be employed to identify relative bottom points in the…

7 hours ago

Largest Ether Outflows Since 2022

Large outflows from Ether funds are in stark contrast to the movements observed in Bitcoin…

8 hours ago

SCOTUS Limits SEC Power on Crypto

The members of the SCOTUS supported two majority opinions that could have serious repercussions for…

9 hours ago

Circle Gets 1st MiCA Stablecoin License

Circle’s USDC and EURC stablecoins become the first fully compliant digital fiat tokens under the…

10 hours ago

Singapore Alerts on Use of Digital Payments in Terrorism

The authorities in Singapore have alerted people about the dangers to security, including terrorists' use…

11 hours ago

CertiK Moves Blockchain Applications to Alibaba Cloud

Blockchain security company CertiK has finished migrating its blockchain applications to the Alibaba Cloud for…

11 hours ago